BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 15, 2026
Breaking News: Ongoing coverage of the Ebola outbreakBreaking News: Viva in vivo! At EHA, in vivo CAR T data continues to impressBreaking News: Ongoing coverage of the Ebola outbreak
Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
BioWorld Science, Conferences RSS Feed RSS

HIV infected cell.
HIV/AIDS

CPI-818 helps elucidate effects of ITK inhibition on HIV latency

Feb. 24, 2023
Current antiretroviral therapies preserve the immune system, reduce HIV-associated morbidity and prevent HIV transmission but still, the virus persistence in CD4 cells remains a crucial factor to battle. Previous studies have explored the role of interleukin-2-inducible tyrosine kinase (ITK) inhibition in lymphoma, allergy and other infectious diseases.
Read More
Immuno-oncology

Anti-IL1RAP CAR NK cells demonstrate higher cytotoxicity against Ewing sarcoma

Feb. 24, 2023
Ewing sarcoma has a poor prognosis, in part due to the small number of active natural killer (NK) cells and lack of specific tumor targeting. Interleukin 1 receptor accessory protein (IL1RAP) has been reported to be highly expressed in Ewing sarcoma cells but minimally expressed in normal tissues. Researchers have designed an NK cell-based CAR approach targeting ILRAP1 for the treatment of Ewing sarcoma.
Read More
Child and mother with pediatrician.
Biomarkers

SP140 loss-of-function polymorphism protects children from developing GVHD

Feb. 23, 2023
Nuclear body protein SP140 is mainly expressed on immune cells such as B and T cells, monocytes or dendritic cells and they are activated by interferon and regulated upon cellular stress, such as during viral infections.
Read More
Cross-section of brain
Neurology/Psychiatric

Ifi27l2a identified as new therapeutic target to reduce brain injury in stroke

Feb. 23, 2023
Microglial cells (MGs) are resident immune cells in the brain, which play a key role in the acute response and chronic recovery to stroke. Investigators at the University of Texas Health Science Center Houston aimed to evaluate MG transcriptomic response to stroke in mouse brain.
Read More
3D illustration of heart cross section
Cardiovascular

Preclinical profile of novel cardiac myosin inhibitor CK-586 disclosed

Feb. 23, 2023
Hypertrophic cardiomyopathy (HCM) is an inherited disorder where different mutations in cardiac myosin lead to hypercontractility of...
Read More
HIV-infected cell
HIV/AIDS

Path to a broadly effective HIV vaccine is coming into focus

Feb. 23, 2023
By Anette Breindl
In the larger picture, the fight against HIV has been a triumph of modern medicine. A patient diagnosed with HIV in the 1980s had a remaining life expectancy of 1 to 2 years. In 2023, they can expect to live another half century. But so far, an HIV vaccine has remained elusive. In the newest phase III failure, Janssen Pharmaceutical Cos. of Johnson & Johnson closed down its Mosaico trial more than a year ahead of schedule, following a data and safety monitoring board’s (DSMB) report saying the study was not expected to hit its primary endpoint.
Read More
Man holding hand up to ear
Ear, Nose & Throat

Researchers create humanized mouse model for DFNA9 carrying the p.P51S variant of COCH gene

Feb. 22, 2023
Researchers from the University of Antwerp reported the characterization of a novel clinically relevant mouse model of DFNA9 (deafness, autosomal dominant 9), an autosomal dominant inherited disorder characterized by vestibular dysfunction and adult-onset progressive hearing loss caused by different heterozygous mutations in the COCH gene.
Read More
Blood smear showing abnormal red blood cells morphology
Biomarkers

GSTA1*B polymorphism impacts outcome of patients with thalassemia under treosulfan-based conditioning regimen

Feb. 22, 2023
The success of the treosulfan-based conditioning regimen in patients with β-thalassemia undergoing hematopoietic cell transplantation (HCT) is limited due to several complications, such as mixed chimerism and graft rejection. Researchers previously found that polymorphisms in the NQO1 or glutathione S-transferase A1 (GSTA1) genes had an impact on treosulfan pharmacokinetics, which then impacted related toxicities after HCT.
Read More
Biomarkers

miR-371a-3p is overexpressed in metastatic seminomas and nonseminomas

Feb. 22, 2023
Recent findings unveiled that high serum levels of the molecular marker microRNA 371 correlate with the clinical stage and metastasis of seminomas (tumor of the testis germ cells) and nonseminomas. The expression of miR-371a-3p was evaluated in a cohort of patients with stage IIA/B seminoma and nonseminoma. Expression of miR-371a-3p was found to be positive in all 12 metastatic patients with seminoma or nonseminoma and was negative in 3 out of 4 nonmetastatic cases.
Read More
3D illustration showing tumor inside prostate gland and closeup view of cancer cells
Biomarkers

RIPK2 drives prostate cancer progression and is a useful prognostic marker

Feb. 21, 2023
Receptor-interacting serine/threonine-protein kinase 2 (RIPK2) is a kinase protein that plays key roles in inflammation and antimicrobial response through the NF-kB signaling pathway, as well as it is known to activate c-MYC, which is involved in the progression of several malignancies, such as prostate cancer.
Read More
Previous 1 2 … 215 216 217 218 219 220 221 222 223 … 3090 3091 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • Illustration of Lactobacillus

    Microbiota modulates the antidepressant effects of GLP-1 analogues

    BioWorld Science
    Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
  • Genome sequence map

    EHA 2026: With new lenses, a changing view on pediatric cancers

    BioWorld
    In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
  • Microscopic image of chronic myeloid leukemia

    Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid

    BioWorld
    Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing